Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of SM03 in Patients With Rheumatoid Arthritis Receiving Methotrexate [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and efficacy of SM03 in rheumatoid arthritis patients on methotrexate has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• SM03

Snippet

Sponsor: SinoMab BioScience Ltd | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED